Dr. Sandeep Mallipattu of the Renaissance School of Medicine (RSOM) at Stony Brook University, investigates cell-to-cell communication within the kidneys. His latest work is supported by a $2.76 million grant that runs through February 2029.
In the study, appearing April 30 in JAMA Surgery, patients treated with SGLT2i had a small but significantly higher risk of postoperative euglycemic ketoacidosis but a lower risk of postoperative acute kidney injury (AKI) and mortality at 30 days post-surgery.
Experts from Cedars-Sinai will present advances in research and clinical innovation at the annual Digestive Disease Week (DDW) scientific conference May 3-6 in San Diego.
Background: Digital health interventions (DHIs) have rapidly evolved and significantly revolutionized the health care system. The quadruple aims of health care (improving population health, enhancing consumer experience, enhancing he...
In a study published in JCI Insight, researchers investigated the combined effects of bazedoxifene and conjugated estrogens in rat models as an alternative to tamoxifen.
JACKSONVILLE, Fl贸rida 鈥� Voc锚 tem se sentido cansado e ganhou peso. Pode ser apenas um sinal de que voc锚 est谩 envelhecendo, mas pode haver uma chance de que esses sintomas gerais sejam causados pelo鈥痟ipotiroidismo. O Dr. Victor Bernet,鈥痚ndocrinologista na Mayo Clinic, explica os fatores de risco e como essa condi莽茫o 茅 diagnosticada e tratada.
JACKSONVILLE, Florida 鈥� You've been feeling fatigued and have gained some weight. It could be just a sign that you're getting older, but these symptoms might be caused by鈥痟ypothyroidism. Victor Bernet, M.D., an鈥痚ndocrinologist at Mayo Clinic, explains risk factors and how the condition is diagnosed and treated.
JACKSONVILLE, Florida 鈥� Usted se ha estado sintiendo cansado y ha ganado peso. Puede ser solo una se帽al de que est谩 envejeciendo, pero puede haber una posibilidad de que estos s铆ntomas generales sean causados por鈥痟ipotiroidismo. El Dr. Victor Bernet,鈥痚ndocrin贸logo en Mayo Clinic, explica los factores de riesgo y c贸mo se diagnostica y trata esta afecci贸n.
噩丕賰爻賵賳賮賷賱貙 賵賱丕賷丞 賮賱賵乇賷丿丕 鈥斮呝嗀� 賮鬲乇丞 賵兀賳鬲 鬲卮毓乇 亘丕賱鬲毓亘 賰賲丕 兀賳賰 丕賰鬲爻亘鬲 亘毓囟 丕賱賵夭賳. 賯丿 賷賰賵賳 匕賱賰 賲噩乇丿 毓賱丕賲丞 毓賱賶 兀賳賰 鬲鬲賯丿賲 亘丕賱毓賲乇貙 賵賱賰賳 賴賳丕賰 丕丨鬲賲丕賱 兀賳 賷賰賵賳 爻亘亘 賴匕賴 丕賱兀毓乇丕囟 丕賱毓丕賲丞 賴賵 賯氐賵乇 丕賱丿乇賯賷丞. 賷卮乇丨 賮賷賰鬲賵乇 亘賷乇賳鬲貙 丿賰鬲賵乇 賮賷 丕賱胤亘 丕禺鬲氐丕氐賷 丕賱睾丿丿 丕賱氐賲丕亍 賮賷 賲丕賷賵 賰賱賷賳賰 毓賵丕賲賱 丕賱禺胤賵乇丞 賵賰賷賮賷丞 鬲卮禺賷氐 丕賱丨丕賱丞 賵毓賱丕噩賴丕.
Virginia Tech researchers at the Fralin Biomedical Research Institute at VTC created the Experimental Beverage Marketplace to test the potential effects of these tax proposals on purchasing and consumption. Its purpose is to ensure that policy is guided by evidence.
Statins are lifesaving to those with high cholesterol, but patients don鈥檛 always take them. A nudge that increased long-term prescriptions could be key
Monell Center investigators identified that GLP-1R agonists, a class of drugs currently used to treat type-2 diabetes and obesity, as a promising therapeutic for managing the metabolic complications associated with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments. They used a genetically engineered mouse model of BBS that displayed the hallmark features of the condition.
Social determinants of health can have a large impact on the health of people living with type 2 diabetes
A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes suggests the condition stems from gradual damage to the pancreas through misregulation of a molecular pathway called the unfolded protein response (UPR). The findings, published in Molecular Metabolism, could one day lead to new ways to treat more common subsets of diabetes, including Types 1 and 2, which affect hundreds of millions worldwide.
Malnutrition-related diabetes鈥攖ypically affecting lean, malnourished teens and young adults in low- and middle-income countries鈥攊s now officially recognized as a distinct form of the disease, known as type 5 diabetes.
Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 海角社区 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right